K983769

Substantially Equivalent

DISTAFLO BYPASS GRAFT

Applicant: Impra, Inc.
Product code: DYF
Advisory panel: Cardiovascular
Date received: 1998-10-26
Decision date: 1998-12-15
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Tempe, AZ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.